In order to bring you the best possible user experience, this site uses Javascript. If you are seeing this message, it is likely that the Javascript option in your browser is disabled. For optimal viewing of this site, please ensure that Javascript is enabled for your browser.
2019 ESC/EAS Guidelines on Dyslipidaemias
Session

Event : ESC Congress 2019

Topic : Lipids

  • Session type : New ESC Guidelines
  • Date : 02 September 2019
  • Time : 08:30 - 10:00

4 presentations in this session

Risk stratification for atherosclerotic cardiovascular disease.

Event : ESC Congress 2019

  • Session : 2019 ESC/EAS Guidelines on Dyslipidaemias
  • Speaker : BA Ference (Cambridge,GB)

Imaging to improve selection of patients for lipid-lowering treatment.

Event : ESC Congress 2019

  • Session : 2019 ESC/EAS Guidelines on Dyslipidaemias
  • Speaker : V Delgado (Leiden,NL)

Formulating appropriate lipid-lowering treatment goals and strategies.

Event : ESC Congress 2019

  • Session : 2019 ESC/EAS Guidelines on Dyslipidaemias
  • Speaker : A Catapano (Milan,IT)

Lipid lowering treatment for selected patient populations.

Event : ESC Congress 2019

  • Session : 2019 ESC/EAS Guidelines on Dyslipidaemias
  • Speaker : F Mach (Geneva,CH)

Get your access to resources

Join now
  • 1ESC Professional Members – access all ESC Congress resources 
  • 2ESC Association Members (Ivory, Silver, Gold) – access your Association’s resources
  • 3Under 40 or in training - with a Combined Membership, access all resources
Join now

Our sponsors

ESC 365 is supported by Bayer, Boehringer Ingelheim and Lilly Alliance, Bristol-Myers Squibb and Pfizer Alliance, Novartis Pharma AG and Vifor Pharma in the form of educational grants. The sponsors were not involved in the development of this platform and had no influence on its content.

logo esc

Our mission: To reduce the burden of cardiovascular disease

Who we are